EBITDA Growth
175.29%
Quarterly · Period ending:
CDNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported175.29%period ending
Latest reported175.29%period ending
CDNA Quarterly EBITDA YoY % (77.04% → 175.29%)
Year-over-year change
High-resolution chart · PNG
CDNA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 175.2886% | |
| 331.4899% | |
| 94.8701% | |
| 312.031% | |
| -1,706.1798% | |
| 73.3137% | |
| 23.2497% | |
| 87.4885% | |
| 101.6334% | |
| 38.9269% | |
| -45.0505% | |
| -50.1053% | |
| -20.4476% | |
| -16.9602% | |
| -0.022% | |
| -36.608% | |
| -2,322.973% | |
| -1,011.5885% | |
| -2,799.1507% | |
| -1,848.0603% | |
| 121.9053% | |
| 150.2557% | |
| 87.8042% | |
| 91.2238% | |
| 33.9378% | |
| 16.8831% | |
| -71.1879% | |
| -210.088% | |
| -67.9104% | |
| -4.5163% | |
| 2.253% | |
| 85.6252% | |
| -82.7605% | |
| 2.7831% | |
| 40.6226% | |
| -358.1306% | |
| 73.694% | |
| 54.8184% | |
| 0.6391% | |
| 14.2999% | |
| -167.794% | |
| -620.7031% | |
| -726.9231% | |
| -1,313.253% | |
| -1,036.2445% | |
| -957.8512% | |
| -1.2658% | |
| 220.2899% | |
| -148.913% | |
| 77.0398% |